Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (400) Arrow Down
Filter Results: (400) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (400)
    • News  (48)
    • Research  (309)
    • Multimedia  (1)
  • Faculty Publications  (248)

Show Results For

  • All HBS Web  (400)
    • News  (48)
    • Research  (309)
    • Multimedia  (1)
  • Faculty Publications  (248)
← Page 12 of 400 Results →
  • March 2004 (Revised May 2005)
  • Case

Shurgard Self-Storage: Expansion to Europe

By: Richard G. Hamermesh and Indra Reinbergs
Shurgard, a U.S.-based firm that rents storage facilities to consumers and small businesses, is considering financing options for rapid expansion of its European operations. Five years after entering Europe, Shurgard Europe has opened 17 facilities in Belgium, France,... View Details
Keywords: Private Equity; Valuation; Business Model; Governing and Advisory Boards; Entrepreneurship; Cross-Cultural and Cross-Border Issues; Service Industry; Belgium; France; Sweden; United States; Europe
Citation
Educators
Purchase
Related
Hamermesh, Richard G., and Indra Reinbergs. "Shurgard Self-Storage: Expansion to Europe." Harvard Business School Case 804-112, March 2004. (Revised May 2005.)
  • March 2002 (Revised June 2003)
  • Case

MAC Development Corporation

By: Richard G. Hamermesh and Colleen McCaffrey
Deals with MAC Development's efforts to develop a 41-acre site near Chicago. Reviews two years of efforts and highlights the remaining issues of: 1) gaining town approval for development and tax reductions, 2) meeting the bank's debt covenants, including finding a... View Details
Keywords: Risk Management; Taxation; Financial Instruments; Borrowing and Debt; Asset Pricing; Construction Industry; Chicago
Citation
Educators
Purchase
Related
Hamermesh, Richard G., and Colleen McCaffrey. "MAC Development Corporation." Harvard Business School Case 802-140, March 2002. (Revised June 2003.)
  • May 1985 (Revised March 1993)
  • Case

General Electric Co.--1984

By: Francis Aguilar and Richard G. Hamermesh
Describes the first four years of Jack Welch's tenure as CEO of the General Electric Co. Deals with the ways Welch has tried to change GE's strategy and planning activities and his attempts to make the company more entrepreneurial. View Details
Keywords: Management Teams; Management Style; Change Management; Strategic Planning; Corporate Strategy; Corporate Entrepreneurship; Organizational Change and Adaptation
Citation
Educators
Purchase
Related
Aguilar, Francis, and Richard G. Hamermesh. "General Electric Co.--1984." Harvard Business School Case 385-315, May 1985. (Revised March 1993.)
  • 11 Dec 2007
  • First Look

First Look: December 11, 2007

Development, edited by Thomas G. Cummings. Sage Publications, Inc., 2007 Abstract When it comes to transforming big corporations, there are two fundamentally different strategies, says Harvard Business... View Details
Keywords: Martha Lagace
  • January 2013 (Revised January 2013)
  • Course Overview Note

The Entrepreneurial Manager: Course Overview, 2013 Winter Term

By: Richard G. Hamermesh, Richard G. Hamermesh and Thomas Eisenmann
Course overview of The Entrepreneurial Manager. View Details
Keywords: Entrepreneurship; Management; Business Education
Citation
Purchase
Related
Hamermesh, Richard G., and Thomas Eisenmann. "The Entrepreneurial Manager: Course Overview, 2013 Winter Term". Harvard Business School Course Overview Note 813-155, January 2013. (Revised January 2013.)
  • August 2013 (Revised October 2013)
  • Case

MedImmune Ventures

By: Richard G. Hamermesh and David Lane
Ron Laufer is the new Senior Managing Director of MedImmune Ventures, the corporate venture capital arm of AstraZeneca, a leading pharmaceuticals firm. Laufer has to decide whether to pursue a high-potential, but very risky, early-stage investment. The decision Laufer... View Details
Keywords: MedImmune; MedImmune Ventures; AstraZeneca; NeuProtect; Corporate Venturing; Biotechnology; Venture Investing; Venture Capital; Health Care and Treatment; Pharmaceutical Industry; Financial Services Industry; Biotechnology Industry; United States; Australia; Europe; London
Citation
Educators
Purchase
Related
Hamermesh, Richard G., and David Lane. "MedImmune Ventures." Harvard Business School Case 814-023, August 2013. (Revised October 2013.)
  • May 2012
  • Supplement

Westlake Lanes: How Can This Business Be Saved? Spreadsheet for Instructors (Brief Case)

By: Richard G. Hamermesh and Alisa Zalosh
Citation
Purchase
Related
Hamermesh, Richard G., and Alisa Zalosh. "Westlake Lanes: How Can This Business Be Saved? Spreadsheet for Instructors (Brief Case)." Harvard Business School Spreadsheet Supplement 124-434, May 2012.
  • November 2012
  • Supplement

Sugar Bowl, Spreadsheet for Students (Brief Case) (CW)

By: Richard G. Hamermesh and Alisa Zalosh
Citation
Purchase
Related
Hamermesh, Richard G., and Alisa Zalosh. "Sugar Bowl, Spreadsheet for Students (Brief Case) (CW)." Harvard Business School Spreadsheet Supplement 913-539, November 2012.
  • November 2012
  • Teaching Note

Sugar Bowl (Brief Case) (TN)

By: Richard G. Hamermesh and Alisa Zalosh
Citation
Purchase
Related
Hamermesh, Richard G., and Alisa Zalosh. "Sugar Bowl (Brief Case) (TN)." Harvard Business School Teaching Note 913-538, November 2012.
  • December 2012
  • Teaching Note

Gene Patents (A) (TN)

By: Richard G. Hamermesh and Matthew Preble
This is the teaching note for case Gene Patents (A). In March 2010, U.S. District Court Judge Robert Sweet overturned 30 years of legal precedent and ruled that unaltered human genes could not be patented. This case reviews patent law and how it relates to our... View Details
Keywords: Biotech; Human Genome; Patents; Genetics; Biotechnology Industry; United States
Citation
Purchase
Related
Hamermesh, Richard G., and Matthew Preble. "Gene Patents (A) (TN)." Harvard Business School Teaching Note 813-099, December 2012.
  • July 2012 (Revised May 2024)
  • Supplement

Lyric Dinner Theater (B)

By: Richard G. Hamermesh and Jim Sharpe
Supplements the (A) Case. Deborah Denenberg reflects on the results and actions taken during the 12 months following her first 6 months on the job. View Details
Keywords: Entrepreneurs; Entrepreneurial Management; Crisis; Turn; Family Business; Financial Crisis; Boards Of Directors; Operations Management; Strategy Implementation; Career Planning; Entrepreneurship; Entertainment and Recreation Industry; United States
Citation
Purchase
Related
Hamermesh, Richard G., and Jim Sharpe. "Lyric Dinner Theater (B)." Harvard Business School Supplement 813-044, July 2012. (Revised May 2024.)
  • October 2010 (Revised June 2015)
  • Teaching Note

MINTing Innovation at NewYork-Presbyterian (A) and (B)

By: Richard G. Hamermesh and David Kiron
Teaching Note for 810004 and 815113. View Details
Keywords: Commercialization; Technological Innovation; Health Industry
Citation
Purchase
Related
Hamermesh, Richard G., and David Kiron. "MINTing Innovation at NewYork-Presbyterian (A) and (B)." Harvard Business School Teaching Note 811-010, October 2010. (Revised June 2015.)
  • April 2009
  • Teaching Note

Amylin Pharmaceuticals: Diabetes and Beyond (TN)

By: Richard G. Hamermesh and Rachel Gordon
Teaching Note for [809011]. View Details
Keywords: Negotiation Deal; Product Development; Success; Commercialization; Governing Rules, Regulations, and Reforms; Resource Allocation; Pharmaceutical Industry
Citation
Purchase
Related
Hamermesh, Richard G., and Rachel Gordon. "Amylin Pharmaceuticals: Diabetes and Beyond (TN)." Harvard Business School Teaching Note 809-127, April 2009.
  • September 2007 (Revised October 2010)
  • Case

DermaCare: Zapping Zits Directly

By: Richard G. Hamermesh and Lauren Barley
DermaCare has developed an innovative new product for the treatment of acne that they hope to sell to consumers via direct-response television. The unconventional nature of the product and its distribution has led the company to seek angel financing. The Silicon Valley... View Details
Keywords: Decision Choices and Conditions; Venture Capital; Investment; Innovation and Invention; Product; California
Citation
Educators
Purchase
Related
Hamermesh, Richard G., and Lauren Barley. "DermaCare: Zapping Zits Directly." Harvard Business School Case 808-064, September 2007. (Revised October 2010.)
  • May 2007
  • Teaching Note

DentalCorp (TN)

By: Richard G. Hamermesh and Erin Seefeld
Keywords: Health; Health Industry
Citation
Purchase
Related
Hamermesh, Richard G., and Erin Seefeld. "DentalCorp (TN)." Harvard Business School Teaching Note 807-163, May 2007.
  • October 2006 (Revised August 2007)
  • Case

Calloway Laboratory: Pee for Profit

By: Richard G. Hamermesh and David Kiron
Describes the formation and rapid growth of a drug-testing company. The company needs to decide whether to enter the painkiller testing market, in addition to growing its drug treatment center business. View Details
Keywords: For-Profit Firms; Health Care and Treatment; Health Testing and Trials; Growth and Development Strategy; Market Entry and Exit; Health Industry
Citation
Educators
Purchase
Related
Hamermesh, Richard G., and David Kiron. "Calloway Laboratory: Pee for Profit." Harvard Business School Case 807-040, October 2006. (Revised August 2007.)
  • May 2006
  • Teaching Note

WuXi PharmaTech (TN)

By: Richard G. Hamermesh and Erin Seefeld
Keywords: Pharmaceutical Industry
Citation
Purchase
Related
Hamermesh, Richard G., and Erin Seefeld. "WuXi PharmaTech (TN)." Harvard Business School Teaching Note 806-180, May 2006.
  • March 2006 (Revised February 2009)
  • Teaching Note

Molecular Insight Pharmaceuticals, Inc. (TN)

By: Richard G. Hamermesh and Erin Seefeld
Teaching Note to (805-067). View Details
Keywords: Pharmaceutical Industry
Citation
Purchase
Related
Hamermesh, Richard G., and Erin Seefeld. "Molecular Insight Pharmaceuticals, Inc. (TN)." Harvard Business School Teaching Note 806-140, March 2006. (Revised February 2009.)
  • January 2006 (Revised May 2007)
  • Supplement

Endo Pharmaceuticals (D): Hatch-Waxman Change

By: Richard G. Hamermesh and Brian DeLacey
Keywords: Change; Pharmaceutical Industry
Citation
Purchase
Related
Hamermesh, Richard G., and Brian DeLacey. "Endo Pharmaceuticals (D): Hatch-Waxman Change." Harvard Business School Supplement 806-067, January 2006. (Revised May 2007.)
  • January 2006 (Revised May 2007)
  • Supplement

Endo Pharmaceuticals (B): Merger Decision

By: Richard G. Hamermesh and Brian DeLacey
Keywords: Mergers and Acquisitions; Pharmaceutical Industry
Citation
Purchase
Related
Hamermesh, Richard G., and Brian DeLacey. "Endo Pharmaceuticals (B): Merger Decision." Harvard Business School Supplement 806-065, January 2006. (Revised May 2007.)
  • ←
  • 12
  • 13
  • …
  • 19
  • 20
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.